Home Health News Ozempic Shows Potential for Alcohol Addiction in Trial By News Health 1 month Ago Share on FacebookShare on Twitter (MedPage Today) — Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving in adults with alcohol use disorder (AUD), a phase II randomized trial showed. At 9 weeks, semaglutide… Source link : https://www.medpagetoday.com/psychiatry/addictions/114191 Author : Publish date : 2025-02-12 18:44:07 Copyright for syndicated content belongs to the linked Source. Categories: Health News Related Content Daily Oral Islatravir and Doravirine Just as Effective as Other ART Regimens for HIV By News Health March 18, 2025 Supranormal EF; Cannabis Use and CVD; Cardiologist's Sex Crime Accusations By News Health March 18, 2025 Future of Canadian Guidelines, Task Force in Doubt By News Health March 18, 2025 Belly Dancer’s Dyskinesia; Doomsday Clock and Alzheimer's; Epstein-Barr and MS By News Health March 18, 2025 Myasthenia Gravis Antibody Types By News Health March 18, 2025 Weird meteorite may be relic of lost planet that no longer exists By News Health March 18, 2025